AOL News has a new home! The Huffington Post.
Click here to visit the new home of Politics Daily!...
...
My friend Julie Levine had everything I lacked: A charmed childhood, beautiful kids. I might have envied her had she not been the nicest person I ever met. And, therefore, a magnet for cancer. (On an Internet bulletin board I once frequented, we joked that compassion and a zest for living were risk factors.) Julie is eight years younger than me, so I assumed she would someday speak at my funeral. Especially once I received a diagnosis of stage III ovarian cancer in 2001. Julie came to my hospital room. She took me to chemo. She and her mother came to my house bearing brisket, fudgy peanut ...
CHICAGO -- Many breast cancer patients can skip aggressive lymph node surgery without increasing their chances of a recurrence or death if their disease shows limited spread, according to a study that has prompted changes in practice. Under current guidelines, the often-debilitating surgery is done if the cancer has spread outside the breast to any lymph nodes. In the study, rates of survival and of patients' remaining cancer-free were just as good whether the women with limited spread - in one or two nearby nodes - had lots more underarm nodes removed or skipped that major surgery. At ...
For some patients with advanced breast cancer, 2011 began with a harrowing close call: A federal contractor announced that Medicare would no longer pay for women in several states to receive treatment with the drug Avastin. This best-selling cancer medicine has clinically demonstrated its ability to give metastatic breast cancer patients more time -- more weeks or months in which the spread of their cancer is halted in its tracks. Nevertheless, the Food and Drug Administration late last year revealed its intention to revoke approval of Avastin for these patients, arguing that the drug ...
WASHINGTON -- Federal health officials said Wednesday they are investigating a possible link between breast implants and a very rare form of cancer, raising new questions about the safety of devices which have been scrutinized for decades. The cancer, known as anaplastic large cell lymphoma, attacks lymph nodes and skin and has been reported in the scar tissue which grows around an implant. The Food and Drug Administration is asking doctors to report all cases of the cancer so the agency can better understand the association. The agency is aware of just 60 cases of the disease worldwide ...
There's an old saying: "Build a better mousetrap and the world will beat a path to your door." It should apply to hospital gowns. Although many doctors and nurses now have the option of wearing scrubs in all sorts of fun patterns and colors, hospital gowns haven't benefited from any sort of fashion update. Nope, they are still paper-thin, still short-sleeved with a tie in the back that does little to cover the backside. Although many patients grumble at wearing these flimsy excuses for clothing, one New Jersey woman got so angry that she decided to make a hospital gown she could wear ...
Rubber wristbands supporting the fight against breast cancer, mostly in shades of pink, are worn by thousands, if not millions, of cancer survivors and their family members every day. Their messages vary depending on the organization that sells them. The breast cancer-awareness bracelet of the moment is edgier than most, carrying the message, "I 'Heart' Boobies." And that edginess has found an interesting and somewhat controversial audience. Students across America -- from Portland, Ore. to Junction City, Kan. to Easton, Pa. -- have been sporting these bands alongside the more ubiquitous ...
(Dec. 16) -- We hate to be the bearer of bad news, but a once-promising treatment for breast cancer has been knocked down several pegs. After reviewing four clinical studies, the Food and Drug Administration wants to yank approval for the controversial and expensive drug Avastin for the treatment of breast cancer. (A European Union panel, meanwhile, says use of Avastin should be limited in treating the disease.) Avastin was given the OK in 2008, under an FDA policy meant to give patients quick access to cutting-edge, potentially life-saving drugs. The catch: Pharma companies have to prove ...
(Dec. 14) -- The tragic death of Elizabeth Edwards has countless Americans asking what more can be done in the search for better treatments for breast cancer. Unfortunately, our nation might be taking a huge step backwards in this fight on Friday. That's the day federal officials decide whether to revoke approval for Avastin for the treatment of late-stage breast cancer. This biologic drug has been clinically demonstrated to give patients more weeks or months in which the spread of their cancer is halted in its tracks. However, an advisory panel to the Food and Drug Administration has ...
Follow Politics Daily
POPULAR
News From Our Partners




Top News
More News
More on Aol
Local News
More Blog/Sites
Sites and Services